Monday - Friday, 6:00 - 7:00 PM ET CNBC's Jim Cramer reviewed Medline, a medical supplies giant that made its market debut Wednesday. He said he'd wait for a pullback to buy the stock after shares ...

Medline’s (MDLN) stock has drawn growing investor attention after surging 41% above its offer price in its highly anticipated New York debut on December 17. However, with the initial IPO excitement ...

Shares of U.S. medical supplies giant Medline jumped in its debut on the Nasdaq on Wednesday after the biggest initial public offering of the year globally. Shares closed up more than 41% at $41 a ...

Medline continues to report on its ESG priorities under four pillars: climate resilience and environmental action, responsible products, people and communities and robust governance. These pillars are ...